- Home
- ARLP vs ACAD Comparison
ARLP vs ACAD Comparison
Compare ARLP & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARLP
- ACAD
- Stock Information
- Founded
- ARLP 1971
- ACAD 1993
- Country
- ARLP United States
- ACAD United States
- Employees
- ARLP N/A
- ACAD N/A
- Industry
- ARLP Coal Mining
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- ARLP Energy
- ACAD Health Care
- Exchange
- ARLP Nasdaq
- ACAD Nasdaq
- Market Cap
- ARLP 3.4B
- ACAD 2.8B
- IPO Year
- ARLP 1999
- ACAD 2004
- Fundamental
- Price
- ARLP $27.28
- ACAD $16.61
- Analyst Decision
- ARLP Strong Buy
- ACAD Buy
- Analyst Count
- ARLP 1
- ACAD 17
- Target Price
- ARLP $29.00
- ACAD $24.00
- AVG Volume (30 Days)
- ARLP 263.2K
- ACAD 1.5M
- Earning Date
- ARLP 04-28-2025
- ACAD 05-07-2025
- Dividend Yield
- ARLP 10.41%
- ACAD N/A
- EPS Growth
- ARLP N/A
- ACAD N/A
- EPS
- ARLP 2.77
- ACAD 1.36
- Revenue
- ARLP $2,448,708,000.00
- ACAD $957,797,000.00
- Revenue This Year
- ARLP N/A
- ACAD $13.07
- Revenue Next Year
- ARLP $3.83
- ACAD $9.97
- P/E Ratio
- ARLP $9.70
- ACAD $12.28
- Revenue Growth
- ARLP N/A
- ACAD 31.85
- 52 Week Low
- ARLP $20.05
- ACAD $14.15
- 52 Week High
- ARLP $30.56
- ACAD $20.68
- Technical
- Relative Strength Index (RSI)
- ARLP 63.37
- ACAD 36.91
- Support Level
- ARLP $26.00
- ACAD $16.86
- Resistance Level
- ARLP $26.71
- ACAD $17.31
- Average True Range (ATR)
- ARLP 0.63
- ACAD 0.51
- MACD
- ARLP 0.24
- ACAD -0.00
- Stochastic Oscillator
- ARLP 95.35
- ACAD 23.24
About ARLP Alliance Resource Partners L.P. Common Units representing Limited Partners Interests
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.